Effect of Teriparatide on Bone Remodeling and Density in Premenopausal Idiopathic Osteoporosis: A Phase II Trial.

CONCLUSIONS: Teriparatide increased BFR and formation markers and was associated with marked aBMD improvements in most premenopausal women (82%) with IOP. PMID: 32876328 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32876328?dopt=Abstract

Source: The Journal of Clinical Endocrinology and Metabolism - September 4, 2020 Category: Endocrinology Authors: Cohen A, Shiau S, Nair N, Recker RR, Lappe JM, Dempster DW, Nickolas TL, Zhou H, Agarwal S, Kamanda-Kosseh M, Bucovsky M, Williams JM, McMahon DJ, Stubby J, Shane E Tags: J Clin Endocrinol Metab Source Type: research